Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK (TheStreet) -- Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round Thursday evening:

Novavax (NVAX) - Get Report: "You're right to be concerned. This is not the right market for this stock. I'd go with Regeneron Pharmaceuticals (REGN) - Get Report."

LAM Research (LRCX) - Get Report: "This one is really good. I like LAM."

MasterCard (MA) - Get Report: "That's a good buy. You definitely want to buy it right here."

Seattle Genetics (SGEN) - Get Report: "I still like it but I like others better, like BioMarin (BMRN) - Get Report and Isis Pharmaceuticals (ISIS) ."

To read a full recap of "Mad Money" on CNBC, click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in MA.